Roche gets CE mark for chronic kidney disease algorithm

FDA approves atezolizumab–lurbinectedin for ES-SCLC

Pharma Tariffs: US Government backtracks

Biologics CDMO Rezon Bio leaves stealth mode

Genmab swallows Merus in US$8bn deal

MSD Secures Option on EVX-B3

Trump Targets Overseas with 100%-Tariff

UniQure’s stocks up after AMT-130 trial win